Pain Management Stocks
Specialized healthcare providers and pharmaceutical developers in this sector focus on the mitigation of acute and chronic physical distress through non-opioid analgesics, neuromodulation devices, and targeted drug delivery systems.
As of Oct 23, 2026, Pain Management has 33 US-listed companies worth $223B combined. The median member moved -2.0% over the past week; CPIX led among the 25 largest at +18.2% and SCLX trailed at -17.0%.
Companies in Pain Management
- VRTX – Vertex Pharmaceuticals Inc, $136B
- HLN – Haleon plc, $45.6B
- ZTS – Zoetis Inc, $33.9B
- ATRC – AtriCure Inc, $3B
- LTGO – Latigo Biotherapeutics, Inc. Common Stock, $1.1B
- PCRX – Pacira BioSciences, Inc., $1B
- BVS – Bioventus Inc, $897M
- COLL – Collegium Pharmaceutical Inc, $701M
- INFU – InfuSystems Holdings Inc, $262M
- ANIK – Anika Therapeutics Inc, $256M
- CPIX – Cumberland Pharmaceuticals Inc, $111M
- TNXP – Tonix Pharmaceuticals Holding Corp, $93.1M
- ECOR – Electrocore LLC, $87.6M
- NRXS – Neuraxis, Inc., $87M
- OKYO – OKYO Pharma Limited, $77.1M
- NTRB – Nutriband Inc, $73.5M
- HRTX – Heron Therapeuti, $58.1M
- DWTX – Dogwood Therapeutics, Inc., $42.5M
- MLSS – Milestone Scientific, $29.6M
- MIRA – MIRA Pharmaceuticals, Inc. Common Stock, $28M
- SCLX – Scilex Holding Company, $19.9M
- ENSC – Ensysce Biosciences Inc, $7.8M
- AMIX – Autonomix Medical, Inc. Common Stock, $4.9M
- SCNX – Scienture Holdings, Inc., $4.5M
- PRFX – Painreform Ltd, $3.5M
- BRTX – BioRestorative Therapies Inc, $3.1M
- SILO – Silo Pharma Inc, $2.5M
- ATXI – Avenue Therapeutics Inc, $1.4M
- SRNE – Sorrento Therape, $441,024
- FEED – ENvue Medical Inc., $415,672
- TRVN – Trevena Inc, $57,010
- BACK – IMAC Holdings Inc, $2,270
- VRPX – Virpax Pharmaceuticals Inc, $248